Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 5:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–26 of 2 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Head Injury With Intracranial Hemorrhage Clear all

Completed Not applicable Interventional Results available

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

NCT04816591

View directory record Official record

Conditions: Chronic Subdural Hematoma
Interventions: Experimental: Interventional Cohort: TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System, Standard of Care Surgery, Experimental: Interventional Cohort: TRUFILL n-BCA Liquid Embolic System, Standard of Care Medical Management; Device · Other
Lead sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.; Industry
Eligibility: 18 Years to 90 Years

Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 31
States / cities: Birmingham, Alabama • Tucson, Arizona • Walnut Creek, California + 28 more

Source: ClinicalTrials.gov public record

Updated May 11, 2026 · Synced May 22, 2026, 5:06 AM EDT

Not yet recruiting No phase listed Observational

Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy

NCT07214623

View directory record Official record

Conditions: Chronic Subdural Hematoma, cSDH, Chronic Subdural Hematomas
Interventions: Neuro endovascular embolic coil; Device
Lead sponsor: Kaneka Medical America LLC; Industry
Eligibility: 18 Years and older

Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Valhalla, New York • Philadelphia, Pennsylvania

Source: ClinicalTrials.gov public record

Updated Oct 8, 2025 · Synced May 22, 2026, 5:06 AM EDT